Patents Assigned to Asahi Pharma Corporation
  • Therapeutic agent for tumor
    Patent number: 8921333
    Abstract: The present invention provides a therapeutic agent for a tumor, particularly a therapeutic agent for drug-resistant cancer, an agent for suppression or prophylaxis of tumor metastasis, and an agent for suppression or prophylaxis of cancer recurrence, containing a nucleic acid containing miR27b or a nucleotide having a nucleotide sequence having an identity of 70% or more with the nucleotide sequence shown by SEQ ID NO: 1 and having a function equivalent to miR27b.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: December 30, 2014
    Assignees: National Cancer Center, Asahi Pharma Corporation
    Inventors: Takahiro Ochiya, Ryou-u Takahashi
  • Indazole compounds as ?3 andrenoceptor agonist
    Patent number: 7511069
    Abstract: Compounds of the general formula (I): or a salt thereof, wherein R1 is a hydrogen atom or the like; R2 is NHSO2R3 or the like; R3 is a (C1-C6)alkyl group or the like; R5 is a hydrogen atom or the like; R6 and R7 may be the same or different and are each independently a hydrogen atom or the like; X is an oxygen atom or the like; Y is an oxygen atom or the like; Z1 to Z6 are a carbon atom or the like; n is an integer of 0 to 6; *1 is an asymmetric carbon atom; and *2 is an asymmetric carbon atom when R5 is other than a hydrogen atom.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: March 31, 2009
    Assignee: Asahi Pharma Corporation
    Inventors: Shiro Miyoshi, Kohei Ogawa